StonvexLoading…
StonvexStonvexStonvexCore line items from NCSM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $183.63M | $162.56M | $142.47M |
Operating Income | $10.54M | $4.33M | $-5.53M |
Net Income | $23.75M | $6.59M | $-3.15M |
EPS (Diluted) | $8.65 | $2.55 | $-1.27 |
Total Assets | $181.20M | $152.81M | $152.03M |
Total Liabilities | $38.10M | $36.70M | $42.64M |
Cash & Equivalents | $36.73M | $25.88M | $16.72M |
Free Cash Flow OCF − CapEx | $20.97M | $11.42M | $2.89M |
Shares Outstanding | 2.55M | 2.51M | 2.44M |